AI: Real Transformation is Coming to Med Comms
What has AI done for med comms lately? Sure, AI can write a term paper, poem, soliloquy – you name it – in a matter...
Featured News
In a World of AI, How Should Communicators Leverage its Power to Drive Diverse, Inclusive Storytelling
In the ever-evolving world of healthcare communications, brands must continue to focus on crafting compelling messages that don’t just reach but authentically resonate with their...
Get Creative with HCP and Patient Influencer Engagement
Healthcare companies have made significant investments in their social media marketing efforts as a way to better reach and connect with patients and healthcare providers....
Addressing Barriers to Vital Cancer Treatment for Minoritized Communities
Inequities in Cancer Screening, Care and Treatment Minoritized populations receive lower-quality healthcare and have less access to cutting-edge medical technologies. In oncology, this means lower...
Real Chemistry’s Latest IRIS Report Reveals Higher Costs to Consumers of GLP-1 Agonist Treatments Obtained in “Gray Market” vs. Through Traditional Healthcare Providers
Online providers and medical spas are charging consumers more than traditional healthcare channels NEW YORK (July 22, 2024) – IRIS by Real Chemistry today released...
Q2 2024 Real Health Equity Check-Up: Innovative Solutions to Address Healthcare Inequities
Welcome to Real Chemistry’s Real Health Equity Check-Up, a quarterly summary of relevant highlights and emerging trends in today’s complex, ever-evolving health equity space. Sign...
ASCO 2024: The Art and Science of New Possibilities in Cancer Care
From May 30th to June 2nd, over 40,000 people from across the oncology community gathered at Chicago’s McCormick Place and online for the 2024 ASCO...
Real Chemistry at ASCO 2024
Connecting to New Possibilities 44,000 in-person and virtual attendees. 200+ sessions. Countless points of inspiration. ASCO was all that and more, as it boldly embraced...
A New Era in Expanded Oncology Innovation
If only we could extend the reach of today’s oncology treatments to help more patients. That’s been an ongoing wish among oncologists. That time is...